Juul intends to challenge the FDA’s move. The company said it would seek to delay the ruling, which would allow it to continue selling while exploring options, including an appeal. “We do not agree with the findings and the FDA decision, and continue to believe that we have provided sufficient information and data based on qualitative research to address all issues raised by the agency,” the company’s chief regulatory officer, Joe Morillo, said in a statement.
Juul is one of the largest companies in the world in the field of smoking by nicotine evaporation. The company, founded in California in 2015 by a former pair of smokers, has promoted its vaporization pods as a healthier alternative to traditional tobacco cigarettes. But the products, which contain a high concentration of nicotine, raised concerns when use among teens exploded, with more than a quarter of high school students using e-cigarettes in 2019, according to a federal survey.